Cargando…
Developing a Noninvasive Procedure Using Labeled Monoclonal Antibody Anti-VEGF (Bevacizumab) for Detection of Endometriosis
The off-label use of bevacizumab labeled with 99mTc as a new radiopharmaceutical for imaging of endometriosis is a promising noninvasive, new clinical procedure. The bevacizumab in monoclonal antibodies targeted at vascular endothelial growth factor (VEGF) is superexpressed in cases of endometriosis...
Autores principales: | Machado, Daniel Escorsim, Perini, Jamila Alessandra, Orlando, Margarida Maria Camoes, Santos-Oliveira, Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4512512/ https://www.ncbi.nlm.nih.gov/pubmed/26240826 http://dx.doi.org/10.1155/2015/751460 |
Ejemplares similares
-
CYP2C19 metabolic estrogen phenotypes and endometriosis risk in Brazilian women
por: Perini, Jamila Alessandra, et al.
Publicado: (2023) -
Combined Effect of the PGR +331C > T, CYP17A1 -34A > G and CYP19A1 1531G > A Polymorphisms on the Risk of Developing Endometriosis
por: Cardoso, Jéssica Vilarinho, et al.
Publicado: (2017) -
Euterpe oleracea Extract (Açaí) Is a Promising Novel Pharmacological Therapeutic Treatment for Experimental Endometriosis
por: Machado, Daniel Escorsim, et al.
Publicado: (2016) -
Anticancer potential, molecular mechanisms and toxicity of Euterpe oleracea extract (açaí): A systematic review
por: Alessandra-Perini, Jéssica, et al.
Publicado: (2018) -
Role of vascular endothelial growth factor polymorphisms (-2578C > A, -460 T > C, -1154G > A, +405G > C and +936C > T) in endometriosis: a case–control study with Brazilians
por: Perini, Jamila Alessandra, et al.
Publicado: (2014)